Globus Medical, Inc. Announces Preliminary Unaudited Sales Guidance for the Fourth Quarter and Full Year Ending December 31, 2015; Revised Earnings Guidance for the Full Year of 2016
January 06, 2016 at 09:20 pm
Share
Globus Medical, Inc. announced preliminary unaudited sales guidance for the fourth quarter and full year ending December 31, 2015. The company anticipates fourth quarter 2015 sales of approximately $142.6 million, growing 10.7% as reported or 11.5% in constant currency against fourth quarter 2014.
Full year 2015 estimated sales are expected to be approximately $544.7 million, growing 14.8% as reported or 16.0% in constant currency against the prior year, exceeding the company's previous guidance of $539 million.
The company established full year 2016 guidance of $583 million in sales and fully diluted earnings per share of $1.20. 2016 EPS guidance reflects an increase in net income in line with the expected sales growth, as well as a positive contribution from the recently-announced suspension of the Medical Device Tax. The full impact of the suspended Medical Device Tax is expected to be about $0.06 per share. 2016 guidance reflects approximately 7% growth in sales and 10% growth in EPS over the expected 2015 results.
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Globus Medical, Inc. Announces Preliminary Unaudited Sales Guidance for the Fourth Quarter and Full Year Ending December 31, 2015; Revised Earnings Guidance for the Full Year of 2016